Introduction {#Sec1}
============

Cancer therapies have changed dramatically during the past century. Even if surgery or radiotherapy are still used as the primary treatments of many types of cancer, chemotherapy plays also an important role to prevent its recurrence \[[@CR1], [@CR2]\]. In fact, chemotherapeutic drugs are most effective when given in combination (combined chemotherapy). In the combined chemotherapy drugs with different mechanisms of action are used, decreasing the possibility that resistant cancer cells will grow up. When drugs with different effects are combined, each drug can be used at its optimal dose, without intolerable side effects \[[@CR3]\]. New anticancer agents are also being tested as well as new combinations tried. Unfortunately, in many cases an objective response rate for treatment is still not satisfactory. There are multiple reasons for chemotherapy failure in patients' treatment, involving a variety of anatomic, pharmacological and biochemical mechanisms. Therefore, instead of unification of cancer treatment for all patients the future is in the personalization of cancer therapy. This generates the needs for adequate assay scheme to efficiently screen new potential drug candidates or/and new drug combinations.

Nowadays, numerous studies demonstrate that the anticancer activity of standard chemotherapeutic agents can be enhanced by using inhibitors of cyclooxygenase-2 (COX-2) enzyme \[[@CR4]\]. Nonsteroidal anti-inflammatory drugs (NSAIDs) i.e. celecoxib (Celbx) in combination with cytostatic drug can improve their antitumor effects \[[@CR5]\].

In order to better predict the clinical response to drugs' combination, a cell culture model that mimic in vivo behaviour is required \[[@CR6]\]. For these purposes, the use of a microfluidic-based cell-culture platform seems to be a promising alternative to the conventional cell culture methods \[[@CR7], [@CR8]\]. The construction of small-scale devices permits also for using of low cell numbers. It can be important especially during anticancer drug screening of cancer cells isolated from patient. Moreover, development of *lab-on-a-chip* systems provides novel methods of mimicking the complexity of in vivo conditions through construction of properly defined microchannels geometry. It enables to create high value of the surface-to-volume-ratio (SAV). High value of SAV in live organisms was also observed, therefore suitable designing of this parameter in microchips is important. Besides, *lab-on-a-chip* devices allow for more accurate modelling of physical situations for both fundamental research and drug development. In specially designed microdevices, the control of essential signals in cellular microenvironments is more precise than in a macroscale \[[@CR9], [@CR10]\]. The cells in organisms are exposed to the microenvironmental signals (i.e. soluble factors, cell-cell interactions, cell-extracellular matrix (ECM), physical forces), which result in activation of cells behaviour. Cellular responses (i.e. self-renewal, differentiation, biosynthesis, metabolism, apoptosis, migration or quiescence) are observed in live tissues \[[@CR9]\]. Usually, examination of these bioprocesses in macroscale (on the 96-well plates) is difficult. However, numerous publications described microtools for simultaneous and accurate controlling of various factors such as: cells differentiation, migration and apoptosis \[[@CR11]--[@CR13]\].

Microsystems are used for high-throughput screening after cells exposition with a few signals, including chemical, biochemical, physical and mechanical factors \[[@CR9], [@CR11]--[@CR13]\]. Automatic concentration gradient generators as well as controlled-diffusive mixing play an essential role especially during the cytotoxicity assays \[[@CR14]\]. First of all, it allows for real-time monitoring of multifunction conditions/factors in a single plate. Numerous protocols of the toxic effect analysis have been established in miniaturized platforms/systems integrated with a mixing gradient \[[@CR12], [@CR15]--[@CR18]\]. Irimia et al. described the microdevice developed in PDMS, which contained two completely separated chemical gradients. They were connected through a system of valves to one main channel and two waste channels. The advantage of this type of gradient was a possibility to manipulate a flow, which could be directed either to the main channel or to the waste channel \[[@CR16]\]. Evaluation of many independent conditions on various long-term cultures was performed for example by Gomez et al. \[[@CR19]\] and Prokop et al. \[[@CR20]\]. Cells chemotactic responses, after exposing to different chemokins, were evaluated on neutrophils, breast cancer cells, human neural stem cells or lung carcinoma cells \[[@CR21]--[@CR26]\]. In turn, Hosokawa et al. \[[@CR27]\] presented a microfluidic device with chemical gradient for a single-cell cytotoxicity assay. The geometry of this microsystem consists also a microcavity array for entrapment of single cells. In special cavities (chambers) the single Hela cells were trapped and treated with six different concentrations of model compound---potassium cyanine (KCN). Results, presented in this paper, indicated that the microsystem could be used for detection of the concentration- and time-dependent cytotoxicity at the single-cell level.

This work presents data of applying microfluidic cell culture system containing concentration gradient generator (CGG) as a platform for evaluation of drugs' combinations. The type of concentration gradient allows generating five different concentrations of two chemotherapeutic agents. We established the cytotoxic effect of Celbx and 5-FU on normal mouse embryo cells (Balb/c 3T3) and human lung carcinoma cells (A549). For this purpose we used an integrated microfluidic gradient system, which can be used as an alternative tool for rapid multidrug exposure examination \[[@CR28]\]. Moreover, response of both tested cell lines treated with the combination of Celbx and 5-FU was examined. These studies allowed for investigation of anticancer properties of Celbx.

Experimental {#Sec2}
============

Biological materials {#Sec3}
--------------------

The A549 (human lung carcinoma cell line) and Balb/c 3T3 (normal mouse embryo cell line) obtained from the ATCC collection (Manassas, VA, USA, [www.lgcstandards-atcc.org](http://www.lgcstandards-atcc.org/)) were used for cytotoxicity assays in both micro- and macroscale experiments. Both macro- and microscale cell cultures were carried out using the same media and regime of medium exchange \[[@CR28]\]. A549 cells were chosen because lung cancer is one of the most common cancers in the world as well as leading cause of cancer death in men and women. Therefore, it gets an important social problem. In turn, Balb/c 3T3 cell line, was chosen because the European Centre of Validation of Alternative Methods (ECVAM) considered this in vitro model system for evaluating the cytotoxicity and morphological transformation of chemicals and metal compounds \[[@CR29]\]. Moreover, Balb/c 3T3 cells represent normal tissue, what seems to be a good model for analysis of anticancer activity of the chosen drugs.

Assays in a microsystem {#Sec4}
-----------------------

The reusable, hybrid (PDMS/glass) microsystem was used during the studies (Fig. [1](#Fig1){ref-type="fig"}). Design and method of fabrication of the microfluidic cell culture system for cytotoxicity tests was presented in details in our previous work \[[@CR30]\]. The inhibitory effect of combination of two drugs (Celbx and 5-FU) was analyzed on the cells introduced and cultured in the microsystem (see [ESM](#MOESM1){ref-type="media"}). However, before these studies the cytotoxic effect of single drug was investigated. Therefore, both the A549 and Balb/c 3T3 cells response on five various concentration of Celbx (range of 0 ÷ 120 μM) and 5-FU (range of 0 ÷ 300 μM) was established in separate tests. After mixing in CGG, in consecutive rows of culture microchambers, five different concentrations of single drug was obtained. After evaluation of the cytotoxic effect of single treatment, multidrug tests in the microsystem were performed. In this purpose, two different solutions of Celbx (120 μM) and 5-FU (300 μM) into the microsystems were pumped. Drugs were introduced through the CGG inlets with a flow rate of 1.2 μL min^−1^ for 50 min. The microdevices with the introduced drugs (in both single and multidrug treatment) were placed in the incubator for the next 24 or 48 h. For each tested drug, the separate microsystem with proper cell line was used. Finally, cell viability assay was performed using fluorescent dyes (see [ESM](#MOESM1){ref-type="media"}).Fig. 1**a** The microfluidic system integrated with concentration gradient generator (CGG) consists of PDMS and glass. **b** Microchambers with Balb/c 3T3 and A549 cells cultured for 24 h

Assays in a macrosystem {#Sec5}
-----------------------

Both cell lines (at a density of 1 × 10^4^ cells per well) were placed into flat bottom 96-well plates and allowed to attach overnight. Growth inhibitory effects of Celbx and 5-FU were evaluated by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay ([www.invitrogen.com](http://www.invitrogen.com/)), which measures mitochondrial activity of viable cells. The cells were simultaneously treated with Celbx and 5-FU or with each drug separately for 24 and 48 h. After the treatment procedure, the medium was removed and cells were incubated for 4 h at 37 °C in 50 μL per well with MTT solution (final concentration 0.5 mg mL^−1^). Formazan crystals were dissolved in 150 μL of 10 % SDS solution per well and the absorbance was measured at 540 nm using a spectrophotometric microplate reader Power Wave XS (Bio-Tek, Winooski, VT, USA).

Statistical analysis {#Sec6}
--------------------

Experimental data are expressed as mean ± standard deviation (SD) from at least four independent experiments. Data were analysed using SigmaPlot version 11 software. Statistical analysis was performed using the one-way ANOVA. Values of *P \< 0.05* were considered to be statistically significant.

Results and discussion {#Sec7}
======================

Cytotoxicity assay {#Sec8}
------------------

Good coherence between the theoretical and experimental data during a flow of solution through the microdevice, particularly in the CGG has been proved \[[@CR28]\]. Results on microsystem operations are given in [ESM](#MOESM1){ref-type="media"}. The geometry of the fabricated microsystem achieved uniform distribution of cells in microchambers. Analysis within 24 h (using a microscope) of introduced A549 and Balb/c 3T3 cells showed good morphology, comparable to control experiments in which cells were cultured in 96-well plates. Figure [1b](#Fig1){ref-type="fig"} shows A549 and Balb/c 3T3 cells cultured in the microchambers of the microsystem for 24 h. Good adhesion to the glass surface was observed. Two cell lines selected for the investigation represent normal and cancer tissue, what seems to be a good model for analysis of anticancer activity of the chosen drugs, i.e. Celbx and 5-FU. The microsystem enabled to analyse of cell morphology and cytotoxicity simultaneously.

Both cultured cell lines were exposured to combination of Celbx with 5-FU. Additionaly, for the comparision the cytotoxic effect of single drug was also evaluated. In our previous work, we described results for incubation of A549 cells with 5-FU \[[@CR28]\]. Here, we investigated the cytotoxic effect of Celbx on A549 and Balb/c 3T3 cells as well as 5-FU on Balb/c 3T3 cells (see [ESM](#MOESM1){ref-type="media"}). Moreover, the cytotoxic effect on the cells after multidrug exposure was investigated.

Both cell lines were simultaneously exposed to Celbx (0--120 μM) and 5-FU (0--300 μM) in the microfluidic device (microsystem). Cells were exposed to different concentration for 24 and 48 h. Figure [2](#Fig2){ref-type="fig"} shows that Celbx and 5-FU, separately dosed, exert time-dependent cytotoxic effect on carcinoma A549 cells. The strongest cytotoxic effect of single drug was determined for concentrations from 60 to 120 μM for Celbx and from 150 to 300 μM for 5-FU. Incubation of the cells with combination of tested drugs enhanced the cytotoxic effect in comparison to drugs introduced separetly. For each period of time (24 and 48 h) viability decrease of A549 cells' after incubtion with combination of Celbx and 5-FU was observed. The ranges of drugs' concentrations, in which enhanced cytotoxic effect is the strongest can be determined (Fig. [2](#Fig2){ref-type="fig"}). Decrease of A549 cells' viability was observed in ranges of Celbx (39 ÷ 83 μM) and 5-FU (202 ÷ 93 μM) for 24 h and Celbx (19 ÷ 117 μM) and 5-FU (253 ÷ 8 μM) for 48 h. The lowest A549 cells' viability (30 %) after 48 h incubation with combination of 60 μM Celbx and 150 μM 5-FU in comparison to single drugs administration (50 %) was determined.Fig. 2Effects of celecoxib (Celbx), 5-fluorouracil (5-FU) or their combination on viability of A549 in microfluidic system and 96-well plates after 24 and 48 h. Data shown presents averages of four independent experiments. *Asterisks* indicate *P* \< 0.05

Similar experiments were performed on Balb/c 3T3 cells. Figure [3](#Fig3){ref-type="fig"} shows that both agents as well as their combinations were less effective on Balb/c 3T3 cells. Exposure to Celbx (without 5-FU), which seems to be the most potent agent, decrease to 65 % Balb/c 3T3 cell viability at the highest concentration tested after 24 and 48 h of incubation. Whereas, in the same conditions (120 μM of Celbx), the viability of the A549 cells decreased to 20 %. The results obtained in this study suggest that Celbx can enhance anticancer activity of 5-FU by stronger inhibition of cancer cell growth as well as indicate its own anticancer activity. However, we observed that application of both drugs enhanced also the cytotoxic effect of the Balb/c 3T3 cells. Balb/c 3T3 cell viability decreased after incubation with all drugs' combination.Fig. 3Effects of celecoxib (Celbx), 5-fluorouracil (5-FU) or their combination on viability of Balb/c 3T3 cells in microfluidic system and 96-well plates after 24 and 48 h. Data shown presents averages of four independent experiments. *Asterisks* indicate *P* \< 0.05

Comparison the toxic effect of the tested drugs between micro and macroscale {#Sec9}
----------------------------------------------------------------------------

The results obtained with the microfluidic device were compared with those obtained using conventional in vitro cell culture method (macrosystem) in a 96-well plate at selected concentrations (Figs. [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}). The presented results show that cell treatment in the microfluidic device lead to a smaller decrease of viability of A549 cells than in 96-well plates. The enhanced cytotoxic effect for both cell lines in micro- and macroscale was observed. The highest discrepancy between both scales for A549 cells 24 h incubated with drugs' combination was established. Our results obtained for single drug treatment in both cultivation types (microsystem and 96-well plate) are more comparable than those obtained for drug combination treatment. Regression analysis indicates significant correlation of Celbx and 5-FU cytotoxicity between two evaluated systems, because high Pearson's correlation coefficients (R2) were calculated. For single treatments, in most cases, we obtained positive correlation coefficient parameters with P values below 0.05 (Table [1](#Tab1){ref-type="table"}).Table 1The Pearson correlation values (R) between microfluidic device (microsystem) and well plate culture (macrosystem) calculated for single treatmentsDrugA549 cellsBalb/c 3T3 cellsMicrosystem/MacrosystemCelbx0.894^a^0.903^a^24 h5-FU0.970^a^0.768^b^Celbx0.999^a^0.805^b^48 h5-FU0.925^a^0.825^ba^The pair of variables with positive correlation coefficients and P value below 0.05 tends to increase together^b^For pairs with P values greater than 0.05, there is no significant relationship between the two variables

Moreover, 5-FU at the highest tested concentration is stronger in the microsystem than in the 96-well plate. Additionally, Balb/c 3T3 cells were more sensitive to drug combinations in the microsystem (Fig. [3](#Fig3){ref-type="fig"}).

Several factors could have influence on these discrepancies in drug efficiency between the evaluated systems. Most likely, the discrepancy between the two evaluated systems could result from the differences in the cell culture conditions and different access of the anticancer drug to the cells cultivated in the macroscale. First of all, in the 96-well plates, cells were cultured in static conditions, while in the microsystem culture media were periodically replaced and cell cultures were rinsed with drugs and solution of CAM and PI. However, the flow of reagents that occurs in our microdevice, can mimic in vivo condition during the provision of drugs and substances into the living body. On the other hand, the cells division in microscale (where SAV is high \[[@CR10]\]) can result from differences in the cells response on the drugs exposure.

Another hypothesis concerning the obtained discrepancy could result from absorption in PDMS of the tested cytotoxic drugs. Therefore, we investigated absorption of drugs, according to previously elaborated procedure utilizing gas chromatography \[[@CR28], [@CR30]\]. We proved that after several tests performed in the same microsystem, the PDMS block did not absorb the 5-FU (data shown in previous publication) as well as Celbx. In the chromatogram of standard solution of Celbx, there were peaks corresponding to Celbx (retention time 16.47 min) and DMSO (retention time 1.33 min). We investigated that the tested PDMS pieces (obtained from the microsystem) contains only DMSO solution (retention time 1.33 min). We proved that in this case differences between micro and macro scale can not result from absorption in PDMS of the tested cytotoxic drugs. However, the usage of other drugs requires examination of their absorption in PDMS.

Conclusions {#Sec10}
===========

This study demonstrated response of human lung carcinoma cells (A549) and normal mouse embryo cells (Balb/c 3T3) cells on the exposure of combination celecoxib (Celbx) with 5-fluorouracil (5-FU). The application of the CGG in the microsystem improved repeatable generation of different drugs concentration. Moreover, during the multidrug studies different mixtures of the tested drugs (Celbx and 5-FU) were obtained automatically and simultaneously. It allows avoiding operator's errors, which can occur during the preparation of the solutions and it enables to obtain reproducible results. The calculated correlations and high values of Pearson parameter between micro- and macroscale have proved that the microsystem can be an alternative tool for performing the multidrug cytotoxicity assays. The results suggest that Celbx, nonsteroidal anti-inflammatory drug (NSAID), inhibits the growth of cancer cells and indicates anticancer properties. We proved that after cells incubation with Celbx the viability of A549 cells was lower than Balb/c 3T3 normal cells. Moreover, Celbx in combination with 5-FU enhances the antitumor activity. The results confirmed that Celbx inhibits the growth of cancer cells as well as indicates its anticancer properties. The results obtained in the microfluidic system were also compared with classical tests (macroscale). Our results indicate that the microfluidic device can be used for testing the cytotoxic effect of drugs' combination. It is important to note that despite of differences between both evaluated systems, the microfluidic device shows the possibility to test the cytotoxic effect of both drugs: Celbx and 5-FU. This comparison (micro with macroscale) proved possibility to perform multidrug tests in microscale. Our results suggest that the fabricated microfluidic system (containing CGG) can be a unique approach for first evaluation of the cellular responses. It gives possibility for development of simplified methods for simultaneous testing of anticancer drugs or other new synthesized compounds, which are potentially biological active. We believe that our investigations improve validation and standardization of microsystem for cytotoxicity assays.
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